Back to results

University of Texas Health Science Center at Houston

Development and Implementation of A Remote Audit to ol For High Dose Rate (Hdr) 192Ir Brachytherapy Using Optically Stimulated Luminescence Dosimetry

Abstract

dc:description.abstract

<p>This work aimed to create a mailable and OSLD-based phantom with accuracy suitable for RPC audits of HDR brachytherapy sources at institutions participating in NCI-funded cooperative clinical trials. An 8 × 8 × 10 cm<sup>3</sup> prototype with two slots capable of holding nanoDot Al<sub>2</sub>O<sub>3</sub>:C OSL dosimeters (Landauer, Glenwood, IL) was designed and built. The phantom has a single channel capable of accepting all <sup>192</sup>Ir HDR brachytherapy sources in current clinical use in the United States. Irradiations were performed with an <sup>192</sup>Ir HDR source to determine correction factors for linearity with dose, dose rate, and the combined effect of irradiation energy and phantom construction. The uncertainties introduced by source positioning in the phantom and timer resolution limitations were also investigated. It was found that the linearity correction factor was where <em>dose</em> is in cGy, which differed from that determined by the RPC for the same batch of dosimeters under <sup>60</sup>Co irradiation. There was no significant dose rate effect. Separate energy+block correction factors were determined for both models of <sup>192</sup>Ir sources currently in clinical use and these vendor-specific correction factors differed by almost 2.6%. For Nucletron sources, this correction factor was 1.026±0.004 (99% Confidence Interval) and for Varian sources it was 1.000±0.007 (99% CI). Reasonable deviations in source positioning within the phantom and the limited resolution of the source timer had insignificant effects on the ability to measure dose. Overall measurement uncertainty of the system was estimated to be ±2.5% for both Nucletron and Varian source audits (95% CI). This uncertainty was sufficient to establish a ±5% acceptance criterion for source strength audits under a formal RPC audit program. Trial audits of eight participating institutions resulted in an average RPC-to-institution dose ratio of 1.000 with a standard deviation of 0.011.</p>

Degree

thesis:*
Name thesis:degree_name
Masters of Science (MS)
Level thesis:degree_level
Thesis (MS)
Year dc:date.available
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Casey, Kevin
Contributors dc:contributor
  • David Followill, Ph.D.
  • Paola Alvarez, M.S.
  • Stephen Kry, Ph.D.

Subjects

dc:subject × 11

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1309

Chain of custody

source
Harvested from
University of Texas Health Science Center at Houston
Base URL
digitalcommons.library.tmc.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Casey, Kevin. Development and Implementation of A Remote Audit to ol For High Dose Rate (Hdr) 192Ir Brachytherapy Using Optically Stimulated Luminescence Dosimetry. Thesis (MS) thesis, 2012. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/249